Cal Wayne Greenlaw
Abstract
Drug induced gynecomastia has infrequently been reported in the medical literature, but is probably more common than is suspected. A case report illustrating spironolactone induced gynecomastia is presented and various aspects of the condition are discussed, including mechanism of action and treatment.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Drug induced gynecomastia has infrequently been reported in the medical literature, but is probably more common than is suspected. A case report illustrating spironolactone induced gynecomastia is presented and various aspects of the condition are discussed, including mechanism of action and treatment.
Key concepts: Gynecomastia, Spironolactone, Medicine, Drug, Dermatology, Pharmacology, Internal medicine, Aldosterone